|
⚲
|
| Keyboard |
| Khaya Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002150248 |
| Sale | 2026-02-05 (0.8 M Offered, 0.2 M Sold) |
| Fund | |
| Phone | 6129653081 |
| Address | 122 Museum Drive Dothan, AL 36303 |
| Source | [EDGAR] |
| Amount Raised ($k) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-08-13 (D) |
| Exemption | 506(b) |
| Minimum | $25,000 |
| Remaining | $650,000 |
| Duration | One year or less |
| Revenue | No Revenues |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Garcia Sebastian | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Harbert Fund Advisors Inc
✚
|
AL | |
|
Park Place Capital Corp
✚
|
AL | |
|
Protective Investment Advisors Inc
✚
|
AL | |
|
Protective Life Corp
✚
|
AL | |
|
Strauss Financial Group Inc
✚
|
AL | |
|
Redmont Venture Partners Inc
✚
|
AL | |
|
Kintail Capital LLC
✚
|
AL | |
|
Bridgeworth LLC
✚
|
AL | |
|
Eastside Management Company II LLC
✚
|
AL | |
|
SIG Capital LLC
✚
|
AL |